Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The AML Channel

Explore the latest updates, including expert interviews, features, podcasts and e-learning

The AML Channel on VJHemOnc is supported by BMS, Gilead Oncologyand Jazz Pharmaceuticals The supporters have no influence over the production of the content.

Welcome to The Acute Myeloid Leukemia (AML) Channel

VJHemOnc brings you the latest and greatest global advances related to the classification, diagnosis, treatment, and management of AML. Speaking with world-leading experts, The AML Channel delivers video interviews, podcasts, roundtable discussions and more.

Hot topics frequently covered on The AML Channel include the use of measurable residual disease (MRD) testing to guide treatment, antibody-based treatments and CAR-T cell therapies.


EHA 2024
ASCO 2024
BSH 2024
EBMT 2024
AACR 2024
ASH 2023


CAR-T & Cellular Therapy
Real-World Data
Trial Updates